Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use
oleh: Mette Deleuran, Danielle Marcoux, Marjolein S. Bruin-Weller, Alan D. Irvine, Eulalia Baselga, Kangmo Ahn, Ana Paula Castro, Ashish Bansal, Jingdong Chao, Gaëlle Bégo-Le-Bagousse, Ana B. Rossi
| Format: | Article |
|---|---|
| Diterbitkan: | Medical Journals Sweden 2021-07-01 |
Deskripsi
Abstract is missing (Short communication)